Monoclonal antibodies to Sarcocystis neurona and uses therefor
View Patent ↗The present invention is directed to particular monoclonal antibodies that find use in the identification and purification of Sarcocystis neurona and related antigens. In particular, these antibodies permit the diagnosis of Sarcocystis related diseases such as equine protozoal myeloencephalitis (EPM).
1. A monoclonal antibody that binds immunologically to a Sarcocystis neurona organism or antigen, designated 2A7-18, deposited with the ATCC as PTA-3418, or 2G5-2, deposited with the ATCC as PTA-3419.
2. The monoclonal antibody of claim 1 , wherein said antibody is designated 2A7-18, deposited with the ATCC as PTA-3418.
3. The monoclonal antibody of claim 1 , wherein said antibody is designated 2G5-2, deposited with the ATCC as PTA-3419.
4. The monoclonal antibody of claim 1 , wherein said antibody comprises a label.
5. The manoclonal antibody of claim 4 , wherein said label is a radioisotope, bead, a ligand, a chemilluminescent molecule, a fluorescent molecule, or an enzyme.
6. The monoclonal antibody of claim 1 , wherein said antibody comprises a therapeutic compound.
7. The monoclonal antibody of claim 6 , wherein said therapeutic compound is a radioisotope or a chemotherapeutic.
8. A kit comprising at least one a monoclonal antibody that binds immunologically to a Sarcocystis neurona organism or antigen, designated 2A7-18, deposited with the ATCC as PTA-3418, or 2G5-2, deposited with the ATCC as PTA-3419, in a suitable container.
9. The kit of claim 8 , comprising both 2A7-18, deposited with the ATCC as PTA-3418, and 2G5-2, deposited with the ATCC as PTA-3419, in suitable containers.
10. The kit of claim 8 , wherein said antibody comprises a label.
11. The kit of claim 10 , wherein said label is a bead, a radioisotope, a ligand, a chemilluminescent molecule, a fluorescent molecule, or an enzyme.